Project Grant R01AG103351
- The National Institute on Aging awarded Kaiser Foundation Hospitals $2.495 million on September 15, 2025, under the Aging Research program (CFDA 93.866) to investigate missed home health care in older adults with Alzheimer's disease and related dementias. The project, titled "Missed Home Health Care in Older Adults with Dementia: Identifying Drivers, Outcomes, and Costs," uses mixed methods to identify correlates and drivers of missed home health care following hospital discharge,...
- The National Institute on Aging awarded Kaiser Foundation Hospitals $825,851 on August 15, 2026, under the Aging Research program (CFDA 93.866) to investigate bi-directional associations between periodontitis, periodontal treatment, and Alzheimer's disease and related dementias in an integrated health system. The project will link detailed dental and medical electronic health records from over 80,000 Kaiser Permanente Northwest members to evaluate whether moderate or severe periodontitis is...
- Summary The National Institute on Aging (NIA) awarded the University of Montana a $3.04 million Project Grant under the Aging Research program (CFDA 93.866) for a four-year project period extending from September 15, 2025, through September 14, 2029. The research investigates the role of neighborhood social exposome dynamics—encompassing social, psychosocial, and sociodemographic exposures at individual and contextual levels—in risk and resilience to Alzheimer's Disease and Related Dementias...
- The National Institute on Alcohol Abuse and Alcoholism awarded Kaiser Foundation Hospitals $759,219 on September 1, 2026, under the Alcohol Research Programs (CFDA 93.273) to conduct early identification research on alcohol-associated liver disease in primary care settings. Kaiser Foundation Hospitals, through its Kaiser Foundation Research Institute division, will recruit 1,300 patients to determine the prevalence of current liver disease using transient elastography across all AUDIT-C...
- The National Institute on Aging awarded the University of California, Berkeley $549,260 on September 1, 2026, under the Aging Research program (CFDA 93.866) to develop advanced large language model-based AI tools that enhance precision in predicting Alzheimer's disease pathology and cognitive outcomes. The research addresses critical gaps in precision medicine for Alzheimer's disease, particularly the need to capture patient heterogeneity, accurately identify treatment candidates for...
- The National Institute on Aging, part of the Department of Health and Human Services National Institutes of Health, awarded $154,960 to the University of Kansas Medical Center Research Institute, Inc. on February 26, 2026, under the Aging Research program (CFDA 93.866). The recipient will conduct research combining cellular and clinical measures to examine bioenergetic contributions to tau phosphorylation in aging and Alzheimer's disease. The work leverages existing clinical data from the KU...
- The National Institute on Alcohol Abuse and Alcoholism, a component of the Department of Health and Human Services National Institutes of Health, awarded Kaiser Foundation Hospitals $2,591,645 on August 5, 2026, under the Alcohol Research Programs (CFDA 93.273) to develop and validate risk-prediction models for alcohol-associated liver disease and metabolic dysfunction-associated steatotic liver disease with unhealthy alcohol intake. The recipient will conduct a multi-method study based at...
- The National Heart, Lung, and Blood Institute awarded Kaiser Foundation Hospitals $193,055 on July 15, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to support Dr. Vy Ho's transition to an independent surgeon-informaticist specializing in abdominal aortic aneurysm diagnosis, surveillance, and treatment. The award funds formal training in computer vision for cardiovascular risk prediction, risk factors for abdominal aortic aneurysms in underrepresented patient...
- The National Institute on Aging awarded $680,086 to The Regents of the University of California, San Francisco (UCSF) on April 1, 2026, under the Aging Research program (CFDA 93.866) to investigate how changes in primary care clinician work effort affect health outcomes for older adults. The research quantifies the number of Medicare patients affected by primary care clinician turnover and sustained reductions in billed clinical effort, identifies factors associated with these work effort...
- The National Institute on Drug Abuse awarded Kaiser Foundation Hospitals $941,958 on March 15, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct longitudinal analysis of cannabis use trajectories across the lifespan. Kaiser's Kaiser Foundation Research Institute, based in Seattle, Washington, will use ten years of electronic health record data from its health system to model cannabis use patterns among more than 331,000 adult patients who completed a single-item...
The National Institute on Aging awarded Kaiser Foundation Hospitals $830,868 on September 3, 2026, under the Aging Research program (CFDA 93.866) to develop nonparametric methods integrating electronic health record and validated research data for aging-related scientific questions. Kaiser Foundation Research Institute will develop machine learning methods to improve accuracy and precision of inverse-probability weighted analyses and validation study design for causal inference and prediction model evaluation. The work addresses methodological challenges in leveraging error-prone electronic health record data—particularly unstructured clinical text extracted via text-mining algorithms—alongside validated data from smaller cohorts, such as the Eye Adult Changes in Thought study. Specific deliverables include methods that properly incorporate machine learning-based weights by combining advances in generalized raking with targeted learning approaches, and improved design frameworks for validation studies in causal inference and prediction model evaluation. The research aims to provide reliable scientific and clinical evidence for prognostic tool development in eye diseases including age-related macular degeneration and for understanding relationships between ophthalmic biomarkers and Alzheimer's disease and related dementias risk. Performance occurs in Seattle, Washington, with a period of performance from award date through June 30, 2031. The award is classified as a Project Grant, the standard assistance type under the NIH Aging Research program.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $830.9k | 9/2/26 |